NO20084590L - Styryl pyridine derivatives and their use in binding and imaging of amyloid plaques - Google Patents
Styryl pyridine derivatives and their use in binding and imaging of amyloid plaquesInfo
- Publication number
- NO20084590L NO20084590L NO20084590A NO20084590A NO20084590L NO 20084590 L NO20084590 L NO 20084590L NO 20084590 A NO20084590 A NO 20084590A NO 20084590 A NO20084590 A NO 20084590A NO 20084590 L NO20084590 L NO 20084590L
- Authority
- NO
- Norway
- Prior art keywords
- imaging
- binding
- pyridine derivatives
- amyloid plaques
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/92—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with a hetero atom directly attached to the ring nitrogen atom
- C07D211/94—Oxygen atom, e.g. piperidine N-oxide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/041—Heterocyclic compounds
- A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K51/0455—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/06—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom
- C07D213/16—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom containing only one pyridine ring
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Physics & Mathematics (AREA)
- Epidemiology (AREA)
- Optics & Photonics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Obesity (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pyridine Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Denne oppfinnelsen vedrører en fremgangsmåte for avbilding av amyloidavsetninger, og styrylpyridinforbindel-ser og fremgangsmåter for fremstilling av radioaktivt merkede styrylpyridin-forbindelser som kan anvendes ved avbilding av amyloidavsetninger. Denne oppfinnelsen vedrører også forbindelser og fremgangsmåter for fremstiling av forbindelser for inhibering av aggre-gasjonen av amyloidproteiner for å danne amyloidavsetninger, og en fremgangsmåte for avlevering av et terapeutisk middel til amyloidavsetninger,This invention relates to a method for imaging amyloid deposits, and to styrylpyridine compounds and methods for preparing radiolabelled styrylpyridine compounds which may be used in imaging amyloid deposits. This invention also relates to compounds and methods for preparing compounds for inhibiting the aggregation of amyloid proteins to form amyloid deposits, and to a method of delivering a therapeutic agent to amyloid deposits.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US78715606P | 2006-03-30 | 2006-03-30 | |
| PCT/US2007/007400 WO2007126733A2 (en) | 2006-03-30 | 2007-03-26 | Styrylpyridine derivatives and their use for binding and imaging amyloid plaques |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20084590L true NO20084590L (en) | 2008-12-29 |
| NO342090B1 NO342090B1 (en) | 2018-03-19 |
Family
ID=38326579
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20084590A NO342090B1 (en) | 2006-03-30 | 2008-10-29 | Styryl pyridine derivatives and their use for bonding and imaging of amyloid plaques |
| NO2018030C NO2018030I1 (en) | 2006-03-30 | 2018-09-11 | Florbetapir (18F) |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO2018030C NO2018030I1 (en) | 2006-03-30 | 2018-09-11 | Florbetapir (18F) |
Country Status (34)
| Country | Link |
|---|---|
| US (3) | US7687052B2 (en) |
| EP (3) | EP2363391A1 (en) |
| JP (1) | JP5290954B2 (en) |
| KR (1) | KR101376807B1 (en) |
| CN (1) | CN101522624B (en) |
| AT (1) | ATE539060T1 (en) |
| AU (1) | AU2007243712B2 (en) |
| BR (1) | BRPI0710225B1 (en) |
| CA (1) | CA2644530C (en) |
| CR (1) | CR10329A (en) |
| CY (3) | CY1113048T1 (en) |
| DK (2) | DK1999109T3 (en) |
| EA (1) | EA017898B1 (en) |
| EC (1) | ECSP088783A (en) |
| ES (2) | ES2378785T3 (en) |
| FR (1) | FR13C0034I2 (en) |
| GT (1) | GT200800201A (en) |
| HR (2) | HRP20120135T1 (en) |
| HU (2) | HUE032660T2 (en) |
| IL (1) | IL193567A (en) |
| LT (1) | LT2363392T (en) |
| LU (1) | LU92232I2 (en) |
| MX (1) | MX2008012527A (en) |
| NO (2) | NO342090B1 (en) |
| NZ (1) | NZ570887A (en) |
| PL (2) | PL1999109T3 (en) |
| PT (2) | PT1999109E (en) |
| RS (2) | RS52222B (en) |
| SG (1) | SG173338A1 (en) |
| SI (2) | SI2363392T1 (en) |
| TW (1) | TWI399366B (en) |
| UA (1) | UA97802C2 (en) |
| WO (1) | WO2007126733A2 (en) |
| ZA (1) | ZA200807955B (en) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5290954B2 (en) * | 2006-03-30 | 2013-09-18 | ザ・トラスティーズ・オブ・ザ・ユニバーシティ・オブ・ペンシルバニア | Styrylpyridine derivatives and their use to bind and image amyloid plaques |
| WO2009004914A1 (en) * | 2007-07-04 | 2009-01-08 | Tohoku University | Pet probe having alkoxy group substituted by fluorine and hydroxy group |
| US8557222B2 (en) | 2008-04-04 | 2013-10-15 | Avid Radiopharmaceuticals, Inc. | Radiopharmaceutical imaging of neurodegenerative diseases |
| CN102271716B (en) * | 2008-12-31 | 2014-11-19 | 阿维德放射性药品公司 | Synthesis of 18F-radiolabeled styrylpyridine from tosylate precursor and its stable pharmaceutical composition |
| CN102471177A (en) * | 2009-07-10 | 2012-05-23 | 拜耳医药股份有限公司 | Usage of low to medium-pressure liquid chromatography for the purification of radiotracers |
| US20120263646A1 (en) | 2009-10-15 | 2012-10-18 | Guerbet | Imaging agents and their use for the diagnostic in vivo of neurodegenerative diseases, notably alzheimer's disease and derivative diseases |
| SG181903A1 (en) * | 2009-12-23 | 2012-07-30 | Piramal Imaging Sa | Formulations suitable for pet imaging with hydrophobic pet agents |
| WO2011141515A1 (en) | 2010-05-14 | 2011-11-17 | Bayer Pharma Aktiengesellschaft | Diagnostic agents for amyloid beta imaging |
| US20140012032A1 (en) * | 2010-06-04 | 2014-01-09 | Piramal Imaging Sa | Method for production of f-18 labeled amyloid beta ligands |
| TWI504414B (en) | 2010-06-04 | 2015-10-21 | Bayer Schering Pharma Ag | Method for production of f-18 labeled aβ ligands |
| BR112012030946A2 (en) | 2010-06-04 | 2016-11-01 | Piramal Imaging Sa | method for producing f-18-labeled beta amyloid binder |
| HRP20171397T4 (en) | 2010-06-04 | 2019-11-15 | Life Molecular Imaging Sa | Method for production of f-18 labeled amyloid beta ligands |
| CN101891674B (en) * | 2010-06-24 | 2012-11-14 | 山东大学 | 4-styryl pyridine compound and preparation method as well as application thereof |
| WO2012051170A2 (en) * | 2010-10-12 | 2012-04-19 | Mayo Foundation For Medical Education And Research | Imaging of meningiomas using phingylbenzothiazole, stilbene, or biphenylalkyne derivatives |
| US20140079635A1 (en) * | 2011-03-30 | 2014-03-20 | Case Western Reserve University | Molecular probes for detecting lipid composition |
| CN106729771A (en) | 2011-04-21 | 2017-05-31 | 加利福尼亚大学董事会 | Functionalized magnetic nanoparticles and the purposes in amyloid deposition and neurofibrillary tangles imaging |
| SG11201401640QA (en) | 2011-10-19 | 2014-07-30 | Piramal Imaging Sa | IMPROVED METHOD FOR PRODUCTION OF F-18 LABELED Aß LIGANDS |
| BR112014024997B1 (en) | 2012-04-10 | 2021-03-09 | Lantheus Medical Imaging, Inc. | radiopharmaceutical synthesis methods |
| JP6099045B2 (en) * | 2013-04-30 | 2017-03-22 | 国立大学法人京都大学 | Triazolopyrimidine derivative compounds |
| JP6041751B2 (en) * | 2013-05-07 | 2016-12-14 | 日本メジフィジックス株式会社 | Styrylpyridine derivative compound |
| JP2014218454A (en) * | 2013-05-07 | 2014-11-20 | 日本メジフィジックス株式会社 | Styrylpyridine derivative compounds |
| CN103645254B (en) * | 2013-11-28 | 2015-01-07 | 江苏省原子医学研究所 | Method for analyzing content of A beta plaque developer precursor AV45 |
| PL3143011T3 (en) | 2014-05-13 | 2021-07-19 | F. Hoffmann-La Roche Ag | Deuterated heterocyclic compounds and their use as imaging agents |
| US10478513B2 (en) | 2015-08-18 | 2019-11-19 | The Regents Of The University Of Califonia | Nitroxide containing amyloid binding agents for imaging and therapeutic uses |
| US10300155B2 (en) | 2015-12-31 | 2019-05-28 | Washington University | Alpha-synuclein ligands |
| CN109400615B (en) * | 2017-08-18 | 2021-07-16 | 上海交通大学医学院附属新华医院 | A kind of coumarin compound targeting β-amyloid and its preparation and application |
| CN108299287A (en) * | 2018-01-02 | 2018-07-20 | 北京师范大学 | There is the N of high-affinity with A β plaque block2S2Class pyridyl group distyryl compound |
| CN114805190A (en) * | 2022-06-08 | 2022-07-29 | 吉林大学第一医院 | Double-column synthesis method of methylaniline Abeta protein developer |
| CN120187703A (en) | 2022-11-14 | 2025-06-20 | 伊莱利利公司 | Polymorphs of flurbiprofezin precursor AV-105 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1992000963A1 (en) * | 1990-07-12 | 1992-01-23 | Yoshitomi Pharmaceutical Industries, Ltd. | Styryl compounds and use thereof as medicine |
| JPH0545875A (en) * | 1991-08-08 | 1993-02-26 | Konica Corp | Photosensitive composition |
| US6020436A (en) * | 1993-03-09 | 2000-02-01 | The Chromaline Corporation | Photosensitive resin composition |
| TW544448B (en) * | 1997-07-11 | 2003-08-01 | Novartis Ag | Pyridine derivatives |
| AU2001239544A1 (en) * | 2000-03-22 | 2001-10-03 | Bf Research Institute, Inc. | Image diagnosis probe based on substituted azobenzene or analogue thereof for disease attributable to amyloid accumulation and composition for image diagnosis containing the same |
| US8007954B2 (en) | 2000-11-09 | 2011-08-30 | The Trustees Of The University Of Pennsylvania | Use of sulfur-containing fuels for direct oxidation fuel cells |
| JP2002182254A (en) | 2000-12-18 | 2002-06-26 | Fuji Photo Film Co Ltd | Nonlinear optical material and method for manufacturing the same |
| CN101003526B (en) * | 2001-08-27 | 2012-02-22 | 宾夕法尼亚州大学理事会 | Stilbene derivatives and their use for binding and imaging amyloid plaques |
| CA2488273A1 (en) | 2002-06-06 | 2003-12-18 | The Trustees Of The University Of Pennsylvania | Ceramic anodes and method of producing the same |
| WO2004016271A1 (en) * | 2002-08-14 | 2004-02-26 | Axxima Pharmaceuticals Ag | Pyrimidones as antiviral agents |
| JP4482352B2 (en) | 2004-03-11 | 2010-06-16 | 本田技研工業株式会社 | Polymer electrolyte fuel cell |
| US7858072B2 (en) * | 2004-12-17 | 2010-12-28 | The Trustees Of The University Of Pennsylvania | Stilbene derivatives and their use for binding and imaging amyloid plaques |
| SI2213652T1 (en) * | 2004-12-17 | 2015-03-31 | The Trustees Of The University Of Pennsylvania | Stilbene derivatives and their use for binding and imaging amyloid plaques |
| JP2008546804A (en) * | 2005-06-24 | 2008-12-25 | ザ・トラスティーズ・オブ・ザ・ユニバーシティ・オブ・ペンシルバニア | Radiolabeled PEGylation of ligands for use as contrast agents |
| JP5290954B2 (en) * | 2006-03-30 | 2013-09-18 | ザ・トラスティーズ・オブ・ザ・ユニバーシティ・オブ・ペンシルバニア | Styrylpyridine derivatives and their use to bind and image amyloid plaques |
| US20080253967A1 (en) | 2007-04-13 | 2008-10-16 | Kung Hank F | Halo-Stilbene Derivatives And Their Use For Binding And Imaging Of Amyloid Plaques |
-
2007
- 2007-03-26 JP JP2009502912A patent/JP5290954B2/en active Active
- 2007-03-26 WO PCT/US2007/007400 patent/WO2007126733A2/en not_active Ceased
- 2007-03-26 PT PT07753982T patent/PT1999109E/en unknown
- 2007-03-26 DK DK07753982.3T patent/DK1999109T3/en active
- 2007-03-26 EP EP11152115A patent/EP2363391A1/en not_active Withdrawn
- 2007-03-26 UA UAA200812698A patent/UA97802C2/en unknown
- 2007-03-26 BR BRPI0710225-9A patent/BRPI0710225B1/en active IP Right Grant
- 2007-03-26 LT LTEP11152124.1T patent/LT2363392T/en unknown
- 2007-03-26 AU AU2007243712A patent/AU2007243712B2/en active Active
- 2007-03-26 SI SI200731938T patent/SI2363392T1/en unknown
- 2007-03-26 SI SI200730865T patent/SI1999109T1/en unknown
- 2007-03-26 ES ES07753982T patent/ES2378785T3/en active Active
- 2007-03-26 US US11/727,401 patent/US7687052B2/en active Active
- 2007-03-26 PL PL07753982T patent/PL1999109T3/en unknown
- 2007-03-26 AT AT07753982T patent/ATE539060T1/en active
- 2007-03-26 CA CA2644530A patent/CA2644530C/en active Active
- 2007-03-26 SG SG2011048477A patent/SG173338A1/en unknown
- 2007-03-26 HR HR20120135T patent/HRP20120135T1/en unknown
- 2007-03-26 DK DK11152124.1T patent/DK2363392T3/en active
- 2007-03-26 ES ES11152124.1T patent/ES2628882T3/en active Active
- 2007-03-26 EA EA200870389A patent/EA017898B1/en not_active IP Right Cessation
- 2007-03-26 EP EP07753982A patent/EP1999109B1/en active Active
- 2007-03-26 PL PL11152124T patent/PL2363392T3/en unknown
- 2007-03-26 HU HUE11152124A patent/HUE032660T2/en unknown
- 2007-03-26 PT PT111521241T patent/PT2363392T/en unknown
- 2007-03-26 RS RS20120077A patent/RS52222B/en unknown
- 2007-03-26 MX MX2008012527A patent/MX2008012527A/en active IP Right Grant
- 2007-03-26 RS RS20170578A patent/RS56171B1/en unknown
- 2007-03-26 NZ NZ570887A patent/NZ570887A/en unknown
- 2007-03-26 EP EP11152124.1A patent/EP2363392B1/en active Active
- 2007-03-26 CN CN2007800116909A patent/CN101522624B/en active Active
- 2007-04-26 TW TW096114833A patent/TWI399366B/en active
-
2008
- 2008-08-05 US US12/186,072 patent/US8506929B2/en active Active
- 2008-08-20 IL IL193567A patent/IL193567A/en active IP Right Grant
- 2008-09-16 ZA ZA2008/07955A patent/ZA200807955B/en unknown
- 2008-09-29 KR KR1020087023884A patent/KR101376807B1/en active Active
- 2008-09-30 GT GT200800201A patent/GT200800201A/en unknown
- 2008-09-30 CR CR10329A patent/CR10329A/en unknown
- 2008-09-30 EC EC2008008783A patent/ECSP088783A/en unknown
- 2008-10-29 NO NO20084590A patent/NO342090B1/en active Protection Beyond IP Right Term
-
2012
- 2012-03-07 CY CY20121100225T patent/CY1113048T1/en unknown
-
2013
- 2013-01-07 US US13/735,609 patent/US8840866B2/en active Active
- 2013-06-26 LU LU92232C patent/LU92232I2/en unknown
- 2013-06-26 FR FR13C0034C patent/FR13C0034I2/en active Active
- 2013-06-27 HU HUS1300028C patent/HUS1300028I1/en unknown
- 2013-06-27 CY CY2013024C patent/CY2013024I1/en unknown
-
2017
- 2017-06-06 HR HRP20170857TT patent/HRP20170857T1/en unknown
- 2017-06-22 CY CY20171100664T patent/CY1119048T1/en unknown
-
2018
- 2018-09-11 NO NO2018030C patent/NO2018030I1/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20084590L (en) | Styryl pyridine derivatives and their use in binding and imaging of amyloid plaques | |
| NO20073650L (en) | Stilbene derivatives and their use for bonding and imaging of amyloid plaques | |
| WO2010009342A3 (en) | Inhibitors of bruton's tyrosine kinase for the treatment of solid tumors | |
| NO20083918L (en) | Dihydridiazepines useful as inhibitors of protein kinases | |
| NO20090469L (en) | Substituted piperidines which increase P53 activity and use thereof | |
| NO332405B1 (en) | Compound of 5-substituted quinoline and isoquinoline derivatives, process for their preparation, their use in the preparation of pharmaceutical agents for the treatment of inflammatory disease and pharmaceutical composition comprising the compound. | |
| NO20085004L (en) | Radioactively labeled dihydrotetrabenazine derivatives and their use as imaging agents | |
| NO20084747L (en) | Tetrahydropteridines useful as inhibitors of protein kinases | |
| NO20092567L (en) | Acetylene endwaters and their use for bonding and imaging of amyloid plaques | |
| NO20084435L (en) | C-MET protein kinase inhibitors | |
| WO2008137619A3 (en) | Thiazoles and pyrazoles useful as kinase inhibitors | |
| NO20083002L (en) | Method for using CD40 binding compounds | |
| WO2008147626A3 (en) | Thiazoles and pyrazoles useful as kinase inhibitors | |
| ATE538114T1 (en) | 4-(PYRIDINE-4-YL)-1H-Ä1,3,5UTRIAZINE-2-ONE DERIVATIVES AS GSK3 BETA INHIBITORS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES | |
| HK1244232A1 (en) | Angiotensin ii receptor agonist for treating pulmonary fibrosis | |
| NO20072567L (en) | Triazoles useful as protein kinase inhibitors | |
| NO20090268L (en) | Benzofuro- and benzothienopyrimidine modulators of the histamine H4 receptor | |
| EA200900091A1 (en) | NEW INDICATIONS FOR THE USE OF DIRECT THROMBIN INHIBITORS IN THE TREATMENT OF CARDIOVASCULAR DISEASES | |
| WO2008061108A3 (en) | Phthalazine derivatives | |
| EA200901249A1 (en) | PROTEINKINAZ BINDING INHIBITORS | |
| WO2006078384A3 (en) | Stilbene derivatives and their use | |
| WO2007100430A3 (en) | Cytisine and acetylcholine analogs and methods of treating mood disorders | |
| EA200901062A1 (en) | USING INHIBITORS OF SOLUBLE EPOXYDHYDROLASE FOR THE PREVENTION AND TREATMENT OF METABOLIC SYNDROME AND RELEVANT DISORDERS | |
| WO2009108755A3 (en) | Pharmaceutical combinations for the treatment of cancer | |
| NO20072209L (en) | Novel chromium-2-one derivatives and their use as monoamine neurotransmitter reuptake inhibitors. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| SPCF | Filing of supplementary protection certificate |
Free format text: PRODUCT NAME: FLORBETAPIR (18F); NORWEGIAN MARKETING AUTHORISATION: 2013.01.14 , NO , EU/1/12/805 , AMYVID Spc suppl protection certif: 2018030 Filing date: 20180911 |
|
| SPCG | Granted supplementary protection certificate |
Free format text: PRODUCT NAME: FLORBETAPIR (18F); REG. NO/DATE: 20130117 Spc suppl protection certif: 2018030 Filing date: 20180911 Extension date: 20280117 |